Mineralys Therapeutics (MLYS) Return on Capital Employed (2023 - 2026)
Quarterly results put Return on Capital Employed at 26.69% for Q1 2026, up 4877.0% from a year ago — trailing twelve months through Mar 2026 was 26.69% (up 4877.0% YoY), and the annual figure for FY2025 was 40.74%, up 4911.0%.
Mineralys Therapeutics has reported Return on Capital Employed over the past 4 years, most recently at 26.69% for Q1 2026.
- Return on Capital Employed reached 26.69% in Q1 2026 per MLYS's latest filing, up from 27.71% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 16.44% in Q2 2023 and bottomed at 86.5% in Q4 2024.
- Median Return on Capital Employed over the past 4 years was 37.5% (2024), compared with a mean of 43.11%.
- The largest annual shift saw Return on Capital Employed crashed -5319bps in 2024 before it surged 5879bps in 2025.
- Over 4 years, Return on Capital Employed stood at 33.31% in 2023, then tumbled by -160bps to 86.5% in 2024, then skyrocketed by 68bps to 27.71% in 2025, then grew by 4bps to 26.69% in 2026.
- Business Quant data shows Return on Capital Employed for MLYS at 26.69% in Q1 2026, 27.71% in Q4 2025, and 41.43% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 21.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.19% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.34% |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -26.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.69% |
| Dec 31, 2025 | -27.71% |
| Sep 30, 2025 | -41.43% |
| Jun 30, 2025 | -62.84% |
| Mar 31, 2025 | -75.45% |
| Dec 31, 2024 | -86.50% |
| Sep 30, 2024 | -64.24% |
| Jun 30, 2024 | -44.18% |
| Mar 31, 2024 | -37.50% |
| Dec 31, 2023 | -33.31% |
| Sep 30, 2023 | -24.72% |
| Jun 30, 2023 | -16.44% |
| Mar 31, 2023 | -19.44% |